⌘K

Login Start Free

Home/Filings/4/0001257433-06-000003

4//SEC Filing

NANCE DAVID G 4

Accession 0001257433-06-000003

CIK 0001018710other

View on SEC.gov Company Profile

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 2:14 PM ET

Size

5.6 KB

Accession

0001257433-06-000003

Insider Transaction Report

Form 4

Period: 2006-01-17

INTROGEN THERAPEUTICS INCINGN

DirectorCEO and President

Transactions

Award
stock option
2006-01-17+250,000→ 250,000 total
Exercise: $5.45From: 2006-01-17Exp: 2016-01-16→ common stock (250,000 underlying)

Footnotes (1)

[F1]Right to buy.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

INTROGEN THERAPEUTICS INC

CIK 0001018710

Entity typeother

Related Parties

1

filerCIK 0001134880

Filing Metadata

Form type: 4
Filed: Jan 18, 7:00 PM ET
Accepted: Jan 19, 2:14 PM ET
Size: 5.6 KB

View on SEC.gov